Synonyms: Nuprin® | sulfadimethyloxazole | Sulfuno® | sulphamoxole
sulfamoxole is an approved drug (1960)
Compound class:
Synthetic organic
Comment: Sulfamoxole is a long-acting sulfonamide antibacterial compound.
|
|
No information available. |
Summary of Clinical Use ![]() |
Sulfamoxole has been evaluated in the treatment of a broad range of bacterial infections including those of the respiratory, genitourinary and gastrointestinal tracts, and the skin and soft tissues [3-4,6]. The drug was developed and first marketed in West Germany (under the trade name Sulfuno) and has been available in other European countries and in the US. However, there is no information regarding current approval for clinical use of this drug on the US FDA or European Medicines Agency (EMA) websites. |
Mechanism Of Action and Pharmacodynamic Effects ![]() |
Sulfonamides are structural analogues of 4-aminobenzoic acid (pABA) an intermediate in the de novo synthesis of folate by some prokaryotes, lower eukaryotes and plants [2]. The antibacterial MMOA is competitive inhibition of bacterial dihydropteroate synthase (DHPS) resulting in a block of folate biosynthesis [1]. |